To prospectively analyze the factors that are currently used for risk-group assignment (MYCN copy number by FISH, DNA content by flow cytometry, and tumor histology using the International Neuroblastoma Pathologic Classification System) in neuroblastoma tumors at the time of diagnosis.
Categories (click each to see list of all clinical trials associated with that category): Pediatric (PEDONC)
Current Status: Open
Phase: N/A (Cancer Control)
Principal Investigator: Beck, Jill
Eligibility: https://clinicaltrials.gov/study/NCT00904241?term=%09NCT00904241&rank=1
Summary
To prospectively analyze the factors that are currently used for risk-group assignment (MYCN copy number by FISH, DNA content by flow cytometry, and tumor histology using the International Neuroblastoma Pathologic Classification System) in neuroblastoma tumors at the time of diagnosis.